Edwards Lifesciences Corporation EW
103.88 USD -1.35 (-1.28%)
Regular-session close
103.88 0.00 0.00%
After hours · Nov 19, 5:15 PM ET
103.49 Day range 105.34
74.66 52-week range 108.00
- YTD
- +21.85%
- 1 year
- +20.76%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 6.07B | 5.44B | 5.01B | 4.46B | 5.23B | |
| 4.73B | 4.32B | 4.03B | 3.74B | 3.98B | |
| 1.10B | 1.38B | 1.28B | 1.46B | 1.57B | |
| 1.07B | 4.17B | 1.40B | 1.52B | 1.50B | |
| 1.83 | 6.97 | 2.30 | 2.44 | 2.38 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.94B | 3.05B | 1.13B | 769.00M | 862.80M | |
| 13.70B | 13.06B | 9.36B | 8.29B | 8.50B | |
| 3.36B | 2.99B | 2.64B | 2.49B | 2.67B | |
| 705.40M | 700.00M | 685.10M | 691.30M | 690.30M | |
| 10.34B | 10.00B | 6.65B | 5.81B | 5.84B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.60B | 542.30M | 895.80M | 1.22B | 1.73B | |
| -712.90M | 2.31B | 173.80M | 252.30M | -1.72B | |
| -956.80M | -983.00M | -711.00M | -1.58B | -356.30M | |
| -260.20M | -252.40M | -253.00M | -244.60M | -325.80M | |
| -119.30M | 1.91B | 375.40M | -94.80M | -332.80M |
